Cookies on our website

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings please view our cookie policy.

Read more Close
Skip Ribbon Commands
Skip to main content
You searched for:
Search

Search

Practice
 
Sub-Practice
 
Sector
 
Sub-Sector
 
Country
 
Language
 
1-10 of 135 results
Results per page: 
Sort by: 
An introduction to CRISPR, what is CRISPR technology and what are the current issues CRISPR technology is facing. An introduction to CRISPR, what is CRISPR technology and what are the current issues CRISPR technology is facing. An introduction to CRISPR, what is CRISPR technology and what are the
21 February 2017
http://www.allenovery.com/publications/en-gb/CRISPRsite
Allen & Overy’s global life sciences practice comprises a multi-disciplinary team of over 90 highly experienced lawyers. Allen & Overy’s global life sciences practice comprises a multi-disciplinary team of over 90 highly experienced lawyers. Allen & Overy’s global life sciences practice comprises a
18 April 2012
http://www.allenovery.com/expertise/sectors/life-sciences
what are the key limitations of the current CRISPR system, who do I need to take a licence from to access the technology, how are non-commercial entities (e.g. university labs) able to access the technology what are the key limitations of the current CRISPR system, who do I need to take a licence
21 February 2017
http://www.allenovery.com/publications/en-gb/CRISPRsite/CRISPRFAQs
In-depth look at different aspects of CRISPR In-depth look at different aspects of CRISPR In-depth look at different aspects of CRISPR In-depth look at different aspects of CRISPR
21 February 2017
http://www.allenovery.com/publications/en-gb/CRISPRsite/CRISPRfeaturearticles
Lawyers who can advise on CRISPR. Lawyers who can advise on CRISPR. Lawyers who can advise on CRISPR. Lawyers who can advise on CRISPR.
21 February 2017
http://www.allenovery.com/publications/en-gb/CRISPRsite/CRISPRcontacts
​According to UN estimates, the global cannabis market is currently worth approximately USD150 billion annually. ​According to UN estimates, the global cannabis market is currently worth approximately USD150 billion annually. According to UN estimates, the global cannabis market is currently
http://www.allenovery.com/publications/en-gb/cannabis
An explanation of the terms Cas, Cas9, Cpf1, crRNA, CRISPR, C2c2, gRNA, PAM, sgRNA, tracrRNA An explanation of the terms Cas, Cas9, Cpf1, crRNA, CRISPR, C2c2, gRNA, PAM, sgRNA, tracrRNA An explanation of the terms Cas, Cas9, Cpf1, crRNA, CRISPR, C2c2, gRNA, PAM, sgRNA, tracrRNA An explanation of
21 February 2017
http://www.allenovery.com/publications/en-gb/CRISPRsite/CRISPRglossary
All you need to know about CRISPR: what is CRISPR, what is the CRISPR patent dispute All you need to know about CRISPR: what is CRISPR, what is the CRISPR patent dispute All you need to know about CRISPR: what is CRISPR, what is the CRISPR patent dispute All you need to know about CRISPR: what is
21 February 2017
http://www.allenovery.com/publications/en-gb/CRISPRsite/CRISPRintroduction
Allen & Overy New York Leveraged Finance partners Alan Rockwell and Todd Koretzky led the team advising the joint lead arrangers and bookrunners on a U.S. syndicated financing for Ares and Leonard Green's acquisition of Press Ganey Associates. Allen & Overy New York Leveraged Finance partners Alan
26 July 2019
http://www.allenovery.com/news/en-gb/articl … -acquisition-of-press-ganey-associates-.aspx
​A&O has climbed the tables in the recently published Adviser Rankings league tables, ranking second by number of FTSE 100 clients. The latest tables list A&O as advising 26 FTSE 100 clients. A&O has climbed the tables in the recently published Adviser Rankings league tables, ranking second by
06 September 2019
http://www.allenovery.com/news/en-gb/articl … strong-performance-in-ftse-100-rankings.aspx


  • Add comment (optional)